- Article
Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations
- Barbara Melosky,
- R. Burkes,
- D. Rayson,
- T. Alcindor,
- N. Shear and
- M. Lacouture
The epidermal growth factor receptor (EGFR) is often overexpressed or dysregulated in a variety of solid tumours, including gastrointestinal (GI) malignancies. Agents targeting the EGFR-mediated signalling pathway are increasingly part of the therape...

